When was Morphle founded?

Morphle was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Morphle located?

Morphle is headquartered in Bengaluru, India. It is registered at Flat No.B706, Ganesh Towers, Bharatnagar, Amraoti Road, Nagpur, Nagpur, Maharashtra, India, 440001.

Which legal entities is Morphle associated with?

Morphle is associated with MORPHLE LABS PRIVATE LIMITED and 2 others.

How many employees does Morphle have?

As of Aug 31, 2026, the latest employee count at Morphle is 107.

Is Morphle a funded company?

Morphle is a funded company, having raised a total of $5.15M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 17, 2020.

How much is Morphle worth?

The latest valuation of Morphle is $***** as of Sep 25, 2025.

When was the latest funding round of Morphle?

Morphle's latest funding was a $***** Series A round on Sep 25, 2025, with participation from 1 investor.

What is the annual revenue of Morphle?

Annual revenue of Morphle is between ₹10 Cr and ₹50 Cr as on Mar 31, 2025

Where does Morphle rank among its competitors?

Morphle ranks 1st amongst 23 active competitors, of which 8 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was AlleSense, which secured $1.79M in May, 2026.

Who are the top competitors of Morphle?

Morphle's top competitors include Scopio Labs, Grundium and Akoya Biosciences. Among them, AlleSense secured the most recent funding round in May, 2026.

Morphle - 2026 Company Profile, Team, Funding, Competitors & Financials

Morphle is a series A company based in Bengaluru (India), founded in 2017 by Anchit Navelkar and Rohit Hiwale. It operates as a Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.. Morphle has raised $5.15M in funding from Y Combinator and Inflexor, with a current valuation of $*****. The company has 23 active competitors, including 8 funded and 2 that have exited. Its top competitors include companies like Scopio Labs, Grundium and Akoya Biosciences.

Company Details

{}

Website: morphlelabs.com
Social
Email ID: *****@morphlelabs.com
Phone Number: +91 **********
Registered Address: Flat No.B706, Ganesh Towers, Bharatnagar, Amraoti Road, Nagpur, Nagpur, Maharashtra, India, 440001

Key Metrics

Founded Year

2017

Location

Bengaluru, India

Stage

Series A

Total Funding

$5.15M in 3 rounds

Latest Funding Round

Series A, Sep 25, 2025, $*****

Post Money Valuation

$***** as on Sep 25, 2025

Investors

Y Combinator & 5 more

Ranked

1^st among 23 active competitors

Annual Revenue

₹10 - ₹50 Cr as on Mar 31, 2025

Employee Count

107 as on Aug 31, 2026

Similar Companies

Scopio Labs & 21 more

View Morphle's full profile

Morphle is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MORPHLE LABS INC. CIN: 7750393 , United States, Active	Dec 13, 2019	-	-	-
MORPHLE TECHNOLOGIES PRIVATE LIMITED CIN: U74999MH2017PTC298991 , India, Active	Aug 24, 2017	0 - ₹10 Cr (As on Mar 31, 2025)	72 (As on May 31, 2025)
MORPHLE LABS PRIVATE LIMITED CIN: U29309KA2020PTC131387 , India, Active	Jan 08, 2020	₹10 - ₹50 Cr (As on Mar 31, 2025)	73 (As on Aug 01, 2025)

Morphle has raised a total funding of $5.15M over 3 rounds. Its first funding round was on Mar 17, 2020. Its latest funding round was a Series A round on Sep 25, 2025 for $*****. 1 investor participated in its latest round. Morphle has 6 institutional investors.

Here is the list of recent funding rounds of Morphle:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 25, 2025	2634276	Series A	6095565	7562688	7756890	9369713
Sep 11, 2021	4649372	Grant (prize money)	1983539	9013046	1388182	HealthVenture
Mar 17, 2020	8028366	Seed	8613233	8995252	Y Combinator	1026437

Access funding benchmarks and valuations. Sign up today!

View details of Morphle's funding rounds and investors

The founders of Morphle are Anchit Navelkar and Rohit Hiwale. Rohit Hiwale is the CEO of Morphle.

Here are the details of Morphle's key team members:

Anchit Navelkar: Former Co-Founder of Morphle and founder of 2 other companies, Iden and Morphle.
Contact Info: 2 email addresses
Rohit Hiwale: Co-Founder & CEO of Morphle and founder of 1 other company.
Contact Info: 1 email address and 1 phone number

View details of Morphle's Founder profiles and Board Members

Morphle's employee count trend

Morphle has 107 employees as of Aug 26. Here is Morphle's employee count trend over the years:

Uncover Morphle's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Morphle include Scopio Labs, Grundium and Akoya Biosciences. Here is the list of Top 10 competitors of Morphle, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Morphle 2017, Bengaluru (India), Series A	Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.	$5.15M	Y Combinator, Inflexor & 4 others	61/100
2nd	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	OTV, OurCrowd & 15 others	58/100
3rd	Grundium 2015, Tampere (Finland), Acquired	Provides portable scanning microscope for medical researcher	$2.37M	Ascend Capital Partners, EIC Fund & 1 others	56/100
4th	Akoya Biosciences 2015, San Francisco (United States), Acquired	Provider of solutions for rapid proteomic profiling	$83.5M	Piper Jaffray, HTIF & 4 others	55/100
5th	PreciPoint 2018, Freising (Germany), Series A	Developer of digital microscopes and micro-positioning systems	$10.2M	Neue Fund, Harmonix & 11 others	41/100
6th	Optra SCAN 2012, Sunnyvale (United States), Series B	Digital pathology solutions for smarter, faster diagnostics and improved patient outcomes	$30M	Molbio Diagnostics, Optra Ventures	39/100
7th	AlleSense 2020, Melbourne (Australia), Seed	Provider of microscopic slides for imaging purposes	$3.49M	Breakthrough Victoria	35/100
8th	Livo 2018, Hyderabad (India), Seed	Manufacturer of next-generation pathology laboratory equipment	$746K	Hyderabad Angels & 6 others	34/100
9th	Macula Vision Systems 2022, Tucson (United States), Seed	Developer of automated computational microscopy solutions for clinical laboratories	-	Brooks Hill Partners, National Science Foundation	29/100
10th	Motic Digital Pathology 2019, United States, Unfunded	Digital pathology solutions for accessible, collaborative, and efficient healthcare	-	-	27/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Morphle's competitors? Click here to see the top ones

Founders own 0.01%, Funds own 7.56% and Parent Entities (largest shareholder) own 92.44%. The net worth of Morphle's founders is INR 2.65L as of Sep 25, 2025.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	0.01%	2.65L	0	0	0	0
Rohit Hiwale	0	0	0	0	0	0
Fund	7.56%	26.4Cr	7885102	7631489	8489802	6621464
Inflexor	6417359	4833300	1619743	7268687	9881075	5403059
Parent Entity	92.44%	324Cr	5087173	5839888	3674183	3925152
Total	100.00%	350Cr	4740228	3298432	1822769	8605424